Literature DB >> 12433065

The nuclear receptor PXR: a master regulator of "homeland" defense.

Isabelle Dussault1, Barry Marc Forman.   

Abstract

Human beings are constantly exposed to toxic chemicals present in food and the environment. We are also challenged by toxic byproducts of chemical reactions within our own bodies. These toxins need to be inactivated or excreted to maintain homeostasis. Pregnane X receptor (PXR) is a promiscuous nuclear receptor that is activated by a diverse array of endogenous and exogenous toxins. On activation, PXR regulates a number of target genes involved in drug metabolism and efflux in two key target tissues: the liver and intestine. In this article, we review the data accumulated in the last few years identifying PXR as a central player in the integration of these pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12433065     DOI: 10.1615/critreveukaryotgeneexpr.v12.i1.30

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  31 in total

Review 1.  Pregnane xenobiotic receptors and membrane progestin receptors: role in neurosteroid-mediated motivated behaviours.

Authors:  C A Frye; C J Koonce; A A Walf
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

2.  Cholesterol detoxification by the nuclear pregnane X receptor.

Authors:  Steven A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 3.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

Review 4.  Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.

Authors:  David S Miller; Björn Bauer; Anika M S Hartz
Journal:  Pharmacol Rev       Date:  2008-06-17       Impact factor: 25.468

Review 5.  The biological actions of dehydroepiandrosterone involves multiple receptors.

Authors:  Stephanie J Webb; Thomas E Geoghegan; Russell A Prough; Kristy K Michael Miller
Journal:  Drug Metab Rev       Date:  2006       Impact factor: 4.518

6.  In silico investigation of agonist activity of a structurally diverse set of drugs to hPXR using HM-BSM and HM-PNN.

Authors:  Yi-Ming Zhang; Mei-Jia Chang; Xu-Shu Yang; Xiao Han
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

7.  Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Deep Kwatra; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2011-08-16       Impact factor: 5.875

8.  Identification of genes controlled by the pregnane X receptor by microarray analysis of mRNAs from pregnenolone 16alpha-carbonitrile-treated rats.

Authors:  Jeffrey Guzelian; Joyce L Barwick; Lawrence Hunter; Tzu L Phang; Linda C Quattrochi; Philip S Guzelian
Journal:  Toxicol Sci       Date:  2006-09-22       Impact factor: 4.849

9.  Role of pregnane xenobiotic receptor in the midbrain ventral tegmental area for estradiol- and 3α,5α-THP-facilitated lordosis of female rats.

Authors:  C A Frye; C J Koonce; A A Walf
Journal:  Psychopharmacology (Berl)       Date:  2014-01-17       Impact factor: 4.530

10.  Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications.

Authors:  Pierpaolo Maisano Delser; Silvia Fuselli
Journal:  Hum Genet       Date:  2013-01-26       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.